Rocket Pharmaceuticals (RCKT) gain after being highlighted as a possible short-squeeze target on CNBC

February 4, 2021 5:16 PM EST
Get Alerts RCKT Hot Sheet
Price: $43.80 +0.62%

Overall Analyst Rating:
    BUY (= Flat)

Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Rocket Pharmaceuticals (NASDAQ: RCKT) gain after being highlighted as a possible short-squeeze target on CNBC



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Momentum Movers, Short Sales, Trader Talk